Assay News and Research

RSS
New microfluidic in vitro kinase radioassay improves efficiency to detect cancer growth

New microfluidic in vitro kinase radioassay improves efficiency to detect cancer growth

National Jewish Health's chronic urticaria diagnostic assay receives US patent

National Jewish Health's chronic urticaria diagnostic assay receives US patent

Researchers develop three-dimensional culture that mimics growth patterns of colon cancer stem cells

Researchers develop three-dimensional culture that mimics growth patterns of colon cancer stem cells

Geron 2010 third quarter revenue increases from $494,000 to $546,000

Geron 2010 third quarter revenue increases from $494,000 to $546,000

Gen-Probe third quarter research revenue increases 70% to $3.4 million

Gen-Probe third quarter research revenue increases 70% to $3.4 million

MRI awarded $31M NIH contract to provide chemistry support for National Toxicology Program

MRI awarded $31M NIH contract to provide chemistry support for National Toxicology Program

Epigenomics presents data on Septin9 biomarker clinical study for colorectal cancer at UEGW

Epigenomics presents data on Septin9 biomarker clinical study for colorectal cancer at UEGW

New computational techniques to overcome obstacles in hard-to-study genes

New computational techniques to overcome obstacles in hard-to-study genes

Evotec, Apeiron Biologics enter collaboration

Evotec, Apeiron Biologics enter collaboration

Elan 2010 third quarter total revenue decreases 2% to $281.4 million

Elan 2010 third quarter total revenue decreases 2% to $281.4 million

AutoGenomics granted FDA 510(k) clearance for INFINITI CYP2C19 Assay

AutoGenomics granted FDA 510(k) clearance for INFINITI CYP2C19 Assay

PPD and VirtualScopics partner to provide medical imaging services

PPD and VirtualScopics partner to provide medical imaging services

Biogen 2010 third quarter revenue increase 5% to $1.2 billion

Biogen 2010 third quarter revenue increase 5% to $1.2 billion

NIH awards Phase I SBIR grant to develop Generic Antibodies for cancer

NIH awards Phase I SBIR grant to develop Generic Antibodies for cancer

Researchers create new high-content assay to increase human embryonic stem cell survival

Researchers create new high-content assay to increase human embryonic stem cell survival

Intercell's IC43 Phase II trial against Pseudomonas aeruginosa infections meets primary endpoint

Intercell's IC43 Phase II trial against Pseudomonas aeruginosa infections meets primary endpoint

New immunoSEQ bioinformatics software platform helps monitor adaptive immune system

New immunoSEQ bioinformatics software platform helps monitor adaptive immune system

Abbott third quarter worldwide sales increase 11.8% to $8.7 billion

Abbott third quarter worldwide sales increase 11.8% to $8.7 billion

Vitro signs contract with HemoGenix to manufacture, distribute stem cell analysis tools

Vitro signs contract with HemoGenix to manufacture, distribute stem cell analysis tools

Spectral commences pivotal Toraymyxin trial for severe sepsis

Spectral commences pivotal Toraymyxin trial for severe sepsis